Sanctuary Advisors LLC Buys New Stake in The Clorox Company $CLX

Sanctuary Advisors LLC acquired a new stake in shares of The Clorox Company (NYSE:CLXFree Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 24,401 shares of the company’s stock, valued at approximately $2,329,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Caitlin John LLC boosted its stake in shares of Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after purchasing an additional 253 shares during the last quarter. Avalon Trust Co purchased a new stake in shares of Clorox during the second quarter worth about $29,000. Darwin Wealth Management LLC acquired a new position in shares of Clorox in the second quarter valued at approximately $29,000. Root Financial Partners LLC raised its position in shares of Clorox by 83.8% in the first quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after buying an additional 145 shares during the last quarter. Finally, SHP Wealth Management purchased a new position in shares of Clorox during the fourth quarter valued at approximately $35,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Clorox stock opened at $105.08 on Wednesday. The firm has a fifty day moving average of $99.35 and a 200-day moving average of $102.92. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $128.90. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80. The firm has a market capitalization of $12.71 billion, a P/E ratio of 21.80, a PEG ratio of 3.35 and a beta of 0.54.

Clorox (NYSE:CLXGet Free Report) last announced its earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, beating the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The business had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.91 billion. During the same period last year, the business posted $2.87 EPS. The company’s revenue was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, analysts predict that The Clorox Company will post 5.8 EPS for the current year.

Clorox Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Shareholders of record on Wednesday, August 12th will be issued a dividend of $1.25 per share. The ex-dividend date of this dividend is Wednesday, August 12th. This represents a $5.00 annualized dividend and a yield of 4.8%. This is an increase from Clorox’s previous quarterly dividend of $1.24. Clorox’s dividend payout ratio (DPR) is 103.73%.

Analyst Upgrades and Downgrades

CLX has been the subject of several recent analyst reports. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $83.00 target price on shares of Clorox in a research note on Friday, May 1st. Evercore set a $99.00 price target on Clorox in a research note on Tuesday, August 4th. Barclays restated an “underweight” rating and set a $84.00 price objective on shares of Clorox in a report on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft set a $98.00 price objective on Clorox in a research report on Tuesday, August 4th. Finally, BNP Paribas Exane dropped their target price on Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a research note on Monday, July 20th. Twelve research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Clorox currently has an average rating of “Reduce” and an average price target of $102.40.

View Our Latest Analysis on CLX

About Clorox

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.